AB-161 is an orally active HBV RNA destabilizer and a PAPD5/7 inhibitor, with its primary action focused in the liver. AB-161 treats Hepatitis B Virus (HBV) infection by lowering the levels of Hepatitis B surface antigen (HBsAg), with an EC50 value of 2.2 nM for HBsAg. AB-161 can be used in the field of HBV infection research[1].
Molecular Weight:
433.41
CAS Number:
[2848560-66-5]
Formula:
C21H21F2N3O5
Target:
HBV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted